Adamis Pharmaceuticals Provides Update Regarding ZIMHI

Posted in Biotech

February 19, 2020 • 2 min read

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today provided an update on the ZIMHI™ New Drug Application (NDA) resubmission process....